Pfizer-BioNTech Evaluating Third COVID-19 Vaccine Dose for Variants
The new trial comes at a time when the FDA has provided guidance on navigating immunogenicity trials for vaccines designed against more transmissible SARS-CoV-2 strains.
Related Articles
Antimicrobial, Wound-Healing Agents Discovered Among Disparate Drug Classes
Selective serotonergic reuptake inhibitors (SSRIs) and beta-adrenergic blockers among agents with potential to mitigate chronic wound infections.
LPOXY Therapeutics Acquires Assets to Advance C difficile Protection for Antibiotic Patients
CEO Larry D Sutton, MD, PhD, elaborates on the company’s strategy and the science behind SIDIPREV to prevent C difficile infections in hospitalized patients.
Doxycycline Postexposure Prophylaxis Prevents STIs Amongst Those Using HIV PrEP
In a retrospective cohort study, a health system found this form of prophylaxis led to substantial reductions in 2 of 3 sexually transmitted infections (STIs)…
Entering Peak Norovirus Season as Cases Rise Across the US
Nationwide norovirus cases have recently increased, followed by an FDA warning for consumers to avoid oysters contaminated in a recent outbreak.
The First Severe Case of Avian Influenza Confirmed in the United States
The Centers for Disease Control and Prevention (CDC) has reported a case in Louisiana where the patient is hospitalized due to the virus, and had…
The Prospective Value of Genetic Testing for Antifungal Susceptibility for Candida Auris
A novel approach may identify resistance earlier and get patients on a proper course of antifungals sooner.
Extended Paxlovid Treatment Shows Mixed Results for Long COVID
A case series of 13 patients suggests that extended courses of Paxlovid could benefit some Long COVID patients, but the results are inconsistent.
Men Experience More Pronounced Health Decline After Lower Respiratory Tract Infections
Older males who had these infections had a statistically significant higher risk for physical and cognitive impairments.
Nirmatrelvir-Ritonavir (Paxlovid) Reduces Short and Long-Term Adverse Outcomes in COVID-19 Patients with Kidney Disease
Recent study highlights Paxlovid’s ability to reduce hospitalizations and mortality in high-risk populations, but underscores the need for personalized treatment.
Top 5 Infectious Disease News Stories Week of December 28-January 3
This week, the CDC MMWR highlights a major blastomycosis outbreak and increased tularemia cases, CHOP’s feedback reports improve antibiotic stewardship in pediatric pneumonia, and more.